Topics

Articles

Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.

Ten23 Expands Sterile Manufacturing Capacity at VIVA 1 Facility

How drugmakers can navigate the program’s pricing challenges and regulatory developments.

A 340B Navigation Guide for Pharmaceutical Manufacturers

Expansion allows facility to provide E2E services in one location, including commercial manufacturing.

AGC Biologics Adds Cell Therapy Suites to Longmont Plant

The company will occupy approximately 62,000 square feet of the new building.  

Astellas to Open New Life Sciences Facility in Cambridge 

The plant— dedicated to cell and gene therapy development—welcomes additional warehouse space, and aims to meet commercial needs.

AGC Biologics Completes Expansion of Milan Manufacturing Site

How the ‘fight-for-the-dollar’ is coming and likely will impact the bundled pricing of industry stakeholders.

Breaking the Pharma Industry’s Bundled Pricing Arrangements

Companies' emphasis on delivering pharmaceuticals is evolving into a collaboration focused on healthcare outcomes.

Wholesalers Step Up Their Partnering

Rob Besse is a Vice President and Subject Matter Expert in
Distribution at Archbow Consulting.

The key questions and considerations for drug manufacturers pursuing an effective alternative distribution model.

Are ADMs a Viable Option for Pharma?

CDMO’s Taoyuan City plant is set to provide customers with products ranging from emulsions to gels. 

Bora Pharmaceuticals Opens New Ophthalmic Manufacturing Plant in Taiwan

CDMO’s Turku addition will span over 69,000 square feet and support the production of ATMPs.

Manufacturing & Packaging